Abstract
Neurocysticercosis (NC) is caused by the establishment of Taenia solium cysticerci in the central nervous system. Previous studies have established that neuroinflammation plays a key role in the severity of the disease. However, the relationship between peripheral and local immune response remains inconclusive. This work studies the peripheral and local immune-inflammatory features and their relationships, toward the identification of potential peripheral immunologic features related to severity. A panel of cytokines was measured in paired cerebrospinal fluid (CSF) and in the supernatant of antigen-specific stimulated peripheral blood mononuclear cells samples (SN) in a total of 31 untreated inflammatory and non-inflammatory NC patients. Increased clinical and radiologic severity was associated with an increased cerebrospinal fluid cell count. A peripheral proliferative depression that negatively correlates with CSF cellularity and TNFα and that positively correlates with SN IL5 was observed in severe NC patients. These results provide evidences to support the systemic proliferative response as a biomarker to monitor the level of neuroinflammation, of possible value in the patients’ follow-up during treatment.
Similar content being viewed by others
References
Del Brutto OH, Sotelo J (1988) Neurocystiercosis: an update. Rev Infect Dis 10:1075–1087
Fleury A, Dessein A, Preux PM, Dumas M, Tapia G, Larralde C, Sciutto E (2004) Symptomatic human neurocysticercosis–age, sex and exposure factors relating with disease heterogeneity. J Neurol 251(7):830–837
Sciutto E, Chavarria A, Fragoso G, Fleury A, Larralde C (2007) The immune response in Taenia solium cysticercosis: protection and injury. Parasite Immunol 29(12):621–636
Villagran J, Olvera J (1988) A clinical and pathological study of 481 autopsy cases. Patología (México) 26:149–156
Fleury A, Gomez T, Alvarez I, Meza D, Huerta M, Chavarria A, Carrillo-Mezo RA, Lloyd C, Dessein A, Preux PM, Dumas M, Larralde C, Sciutto E, Fragoso G (2003) High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiol 22(2):139–145
Sánchez AL, Lindbäck J, Schantz PM, Sone M, Sakai H, Medina MT, Ljungström I (1999) A population-based, case-control study of Taenia solium taeniasis and cysticercosis. Ann Trop Med Parasitol 93(3):247–258
Sáenz B, Ruíz-Garcia M, Jiménez E, Hernández-Aguilar J, Suastegui R, Larralde C, Sciutto E, Fleury A (2006) Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults. Pediatr Infect Dis J 25(9):801–803
Singhi P, Singhi S (2004) Neurocysticercosis in children. J Child Neurol 19(7):482–492
Aguilar-Rebolledo F, Cedillo-Rivera R, Llaguno-Violante P, Torres-López J, Muñoz-Hernández O, Enciso-Moreno JA (2001) Interleukin levels in cerebrospinal fluid from children with neurocysticercosis. Am J Trop Med Hyg 64(1–2):35–40
Bueno EC, Vaz AJ, Machado LR, Livramento JA, Avila SL, Ferreira AW (2001) Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis. Clin Exp Immunol 126(2):304–310
Bueno EC, dos Ramos Machado L, Livramento JA, Vaz AJ (2004) Cellular immune response of patients with neurocysticercosis (inflammatory and non-inflammatory phases). Acta Trop 91(2):205–213
Chavarría A, Fleury A, Garcia E, Marquez C, Fragoso G, Sciutto E (2005) Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Clin Immunol 116(3):271–278
Grewal JS, Kaur S, Bhatti G, Sawhney IM, Ganguly NK, Mahajan RC, Malla N (2000) Cellular immune responses in human neurocysticercosis. Parasitol Res 86(6):500–503
Medina-Escutia E, Morales-Lopez Z, Proano JV, Vazquez J, Bermudez V, Navarrete VO, Madrid-Marina V, Laclette JP, Correa D (2001) Cellular immune response and Th1/Th2 cytokines in human neurocysticercosis: lack of immune suppression. J Parasitol 87:587–590
Restrepo BI, Aguilar MI, Melby PC, Teale JM (2001) Analysis of the peripheral immune response in patients with neurocysticercosis: evidence for T cell reactivity to parasite glycoprotein and vesicular fluid antigens. Am J Trop Med Hyg 65(4):366–370
Restrepo BI, Alvarez JI, Castano JA, Arias LF, Restrepo M, Trujillo J, Colegial CH, Teale JM (2001) Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect Immun 69(7):4554–4560
Rolfs A, Muhlschlegel F, Jansen-Rosseck R, Martins AR, Bedaque EA, Tamburus WM, Pedretti L, Schult G, Feldmeier H, Kremsner P (1995) Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology 45(3 Pt 1):532–538
Chavarría A, Fleury A, Bobes R, Morales J, Fragoso G, Sciutto E (2006) A depressed peripheral cellular immune response is related with symptomatic neurocysticercosis. Microbes Infect 8(4):1082–1089
Evans CA, Garcia HH, Hartnell A, Gilman RH, Jose PJ, Martinez M, Remick DG, Williams TJ, Friedland JS (1998) Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect Immun 66:4522–4525
Rodrigues V Jr, de-Mello FA, Magalhaes EP, Ribeiro SB, Marquez JO (2000) Interleukin-5 and interleukin-10 are major cytokines in cerebrospinal fluid from patients with active neurocysticercosis. Braz J Med Biol Res 33(9):1059–1063
Chavarría A, Roger B, Fragoso G, Tapia G, Fleury A, Dumas M, Dessein A, Larralde C, Sciutto E (2003) TH2 profile in asymptomatic Taenia solium human neurocysticercosis. Microbes Infect 5(12):1109–1115
Rosas N, Sotelo J, Nieto D (1986) ELISA in the diagnosis of neurocysticercosis. Arch Neurol 43:353–356
Gaur U, Aggarwal BB (2003) Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66(8):1403–1408
Pott MC, Tarelli R, Ferrari CC, Sarchi MI, Pitossi FJ (2008) Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson’s disease. Brain 131(7):1880–1894
Taoufik Y, de Herve MG, Giron-Michel J, Durali D, Cazes E, Tardieu M, Azzarone B, Delfraissy JF et al (2001) Human microglial cells express a functional IL-12 receptor and produce IL-12 following IL-12 stimulation. Eur J Immunol 31:3228–3239
Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T, Carson DA (1998) B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 167:1253–1258
Ghaffar O, Lavigne F, Kamil A, Renzi P, Hamid Q (1998) Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngol Head Neck Surg 118(4):504–511
Karlen S, De Boer ML, Lipscombe RJ, Lutz W, Mordvinov VA, Sanderson CJ (1998) Biological and molecular characteristics of interleukin-5 and its receptor. Int Rev Immunol 16(3–4):227–247
Oukka M (2008) Th17 cells in immunity and autoimmunity. Ann Rheum Dis 67(Suppl 3):iii26-9M
Aloisi F, Ambrosini E, Columba-Cabezas S, Magliozzi R, Serafini B (2001) Intracerebral regulation of immune responses. Ann Med 33(8):510–515
Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, Dantzer R, Kelley KW (2001) Interleukin-10 in the brain. Crit Rev Immunol 21(5):427–449
Tiemessen MM, Kunzmann S, Schmidt-Weber CB, Garssen J, Bruijnzeel-Koomen CA, Knol EF, van Hoffen E (2003) Transforming growth factor-beta inhibits human antigen-specific CD4 + T cell proliferation. Int Immunol 15(12):1495–1504
Vitkovic L, Maeda S, Sternberg E (2001) Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation 9(6):295–312
Hartmann S, Lucius R (2003) Modulation of host immune responses by nematode cystatins. Int J Parasitol 33(11):1291–1302
McFarlane E, Perez C, Charmoy M, Allenbach C, Carter KC, Alexander J, Tacchini-Cottier F (2008) Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun 76(2):532–541
Wilson EH, Wille-Reece UF, Dzierszinski F, Hunter CA (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165:63–74
Herrera LA, Tato P, Molinari JL, Perez E, Dominguez H, Ostrosky-Wegman P (2003) Induction of DNA damage in human lymphocytes treated with a soluble factor secreted by Taenia solium metacestodes. Teratog Carcinog Mutagen Suppl 1:79–83
Tato P, Fernandez AM, Solano S, Borgonio V, Garrido EJ, Sepulveda J, Molinari JL (2004) A cysteine protease from Taenia solium metacestodes induce apoptosis in human CD4+ T-cells. Parasitol Res 92(3):197–204
White AC Jr, Robinson P, Kuhn R (1997) Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol 66:209–230
Liu ZG (2005) Molecular mechanism of TNF signaling and beyond. Cell Res 15(1):24–27
Xu G, Shi Y (2007) Apoptosis signaling pathways and lymphocyte homeostasis. Cell Res 17(9):759–771
Acknowledgments
This work was supported by Consejo Nacional de Ciencia y Tecnología 46953-m and 100708. Authors are grateful to the Instituto Nacional de Neurología y Neurocirugía, Mexico, for their support to this project. Isabel Pérez Montfort and Juan Francisco Rodríguez proofread the English version of this manuscript.
Ethical standard
The present study fulfilled all regulations for research with human subjects required by Mexican laws and International regulations. It also complied with all ethical aspects considered in the General Rules of Health for Clinical Investigation. The protocol was approved by the ethics committee of the Instituto Nacional de Neurología y Neurocirugía, México, and written informed consent was obtained from all individuals. All participants volunteered to enter the study. Patients were informed that sera and CSF samples obtained during their hospital studies would be used for this work. All results were confidential.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sáenz, B., Fleury, A., Chavarría, A. et al. Neurocysticercosis: local and systemic immune-inflammatory features related to severity. Med Microbiol Immunol 201, 73–80 (2012). https://doi.org/10.1007/s00430-011-0207-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-011-0207-0